• Something wrong with this record ?

Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation

JN. May, SK. Golombek, M. Baues, A. Dasgupta, N. Drude, A. Rix, D. Rommel, S. von Stillfried, L. Appold, R. Pola, M. Pechar, L. van Bloois, G. Storm, AJC. Kuehne, F. Gremse, B. Theek, F. Kiessling, T. Lammers

. 2020 ; 10 (4) : 1948-1959. [pub] 20200112

Language English Country Australia

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc21012922

Rationale: The blood-brain barrier (BBB) is a major obstacle for drug delivery to the brain. Sonopermeation, which relies on the combination of ultrasound and microbubbles, has emerged as a powerful tool to permeate the BBB, enabling the extravasation of drugs and drug delivery systems (DDS) to and into the central nervous system (CNS). When aiming to improve the treatment of high medical need brain disorders, it is important to systematically study nanomedicine translocation across the sonopermeated BBB. To this end, we here employed multimodal and multiscale optical imaging to investigate the impact of DDS size on brain accumulation, extravasation and penetration upon sonopermeation. Methods: Two prototypic DDS, i.e. 10 nm-sized pHPMA polymers and 100 nm-sized PEGylated liposomes, were labeled with fluorophores and intravenously injected in healthy CD-1 nude mice. Upon sonopermeation, computed tomography-fluorescence molecular tomography, fluorescence reflectance imaging, fluorescence microscopy, confocal microscopy and stimulated emission depletion nanoscopy were used to study the effect of DDS size on their translocation across the BBB. Results: Sonopermeation treatment enabled safe and efficient opening of the BBB, which was confirmed by staining extravasated endogenous IgG. No micro-hemorrhages, edema and necrosis were detected in H&E stainings. Multimodal and multiscale optical imaging showed that sonopermeation promoted the accumulation of nanocarriers in mouse brains, and that 10 nm-sized polymeric DDS accumulated more strongly and penetrated deeper into the brain than 100 nm-sized liposomes. Conclusions: BBB opening via sonopermeation enables safe and efficient delivery of nanomedicine formulations to and into the brain. When looking at accumulation and penetration (and when neglecting issues such as drug loading capacity and therapeutic efficacy) smaller-sized DDS are found to be more suitable for drug delivery across the BBB than larger-sized DDS. These findings are valuable for better understanding and further developing nanomedicine-based strategies for the treatment of CNS disorders.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012922
003      
CZ-PrNML
005      
20210507104854.0
007      
ta
008      
210420s2020 at f 000 0|eng||
009      
AR
024    7_
$a 10.7150/thno.41161 $2 doi
035    __
$a (PubMed)32042346
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a at
100    1_
$a May, Jan-Niklas $u Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany
245    10
$a Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation / $c JN. May, SK. Golombek, M. Baues, A. Dasgupta, N. Drude, A. Rix, D. Rommel, S. von Stillfried, L. Appold, R. Pola, M. Pechar, L. van Bloois, G. Storm, AJC. Kuehne, F. Gremse, B. Theek, F. Kiessling, T. Lammers
520    9_
$a Rationale: The blood-brain barrier (BBB) is a major obstacle for drug delivery to the brain. Sonopermeation, which relies on the combination of ultrasound and microbubbles, has emerged as a powerful tool to permeate the BBB, enabling the extravasation of drugs and drug delivery systems (DDS) to and into the central nervous system (CNS). When aiming to improve the treatment of high medical need brain disorders, it is important to systematically study nanomedicine translocation across the sonopermeated BBB. To this end, we here employed multimodal and multiscale optical imaging to investigate the impact of DDS size on brain accumulation, extravasation and penetration upon sonopermeation. Methods: Two prototypic DDS, i.e. 10 nm-sized pHPMA polymers and 100 nm-sized PEGylated liposomes, were labeled with fluorophores and intravenously injected in healthy CD-1 nude mice. Upon sonopermeation, computed tomography-fluorescence molecular tomography, fluorescence reflectance imaging, fluorescence microscopy, confocal microscopy and stimulated emission depletion nanoscopy were used to study the effect of DDS size on their translocation across the BBB. Results: Sonopermeation treatment enabled safe and efficient opening of the BBB, which was confirmed by staining extravasated endogenous IgG. No micro-hemorrhages, edema and necrosis were detected in H&E stainings. Multimodal and multiscale optical imaging showed that sonopermeation promoted the accumulation of nanocarriers in mouse brains, and that 10 nm-sized polymeric DDS accumulated more strongly and penetrated deeper into the brain than 100 nm-sized liposomes. Conclusions: BBB opening via sonopermeation enables safe and efficient delivery of nanomedicine formulations to and into the brain. When looking at accumulation and penetration (and when neglecting issues such as drug loading capacity and therapeutic efficacy) smaller-sized DDS are found to be more suitable for drug delivery across the BBB than larger-sized DDS. These findings are valuable for better understanding and further developing nanomedicine-based strategies for the treatment of CNS disorders.
650    _2
$a zvířata $7 D000818
650    _2
$a hematoencefalická bariéra $x diagnostické zobrazování $x metabolismus $7 D001812
650    _2
$a mozek $x diagnostické zobrazování $7 D001921
650    _2
$a nemoci mozku $x farmakoterapie $7 D001927
650    _2
$a lékové transportní systémy $x metody $7 D016503
650    _2
$a fluorescenční barviva $x aplikace a dávkování $7 D005456
650    _2
$a liposomy $x aplikace a dávkování $7 D008081
650    _2
$a myši $7 D051379
650    _2
$a myši nahé $7 D008819
650    _2
$a mikrobubliny $7 D045423
650    _2
$a nanomedicína $x metody $7 D050997
650    _2
$a optické zobrazování $x metody $7 D061848
650    _2
$a ultrasonografie $x metody $7 D014463
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Golombek, Susanne K $u Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany
700    1_
$a Baues, Maike $u Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany
700    1_
$a Dasgupta, Anshuman $u Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany
700    1_
$a Drude, Natascha $u Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany
700    1_
$a Rix, Anne $u Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany
700    1_
$a Rommel, Dirk $u DWI - Leibniz Institute for Interactive Materials, RWTH Aachen University, Aachen, Germany
700    1_
$a von Stillfried, Saskia $u Institute of Pathology, University Clinic RWTH Aachen, Aachen, Germany
700    1_
$a Appold, Lia $u Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany
700    1_
$a Pola, Robert $u Czech Academy of Sciences, Institute of Macromolecular Chemistry, Prague, Czech Republic
700    1_
$a Pechar, Michal $u Czech Academy of Sciences, Institute of Macromolecular Chemistry, Prague, Czech Republic
700    1_
$a van Bloois, Louis $u Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
700    1_
$a Storm, Gert $u Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
700    1_
$a Kuehne, Alexander J C $u DWI - Leibniz Institute for Interactive Materials, RWTH Aachen University, Aachen, Germany $u Institute of Organic and Macromolecular Chemistry, Ulm University, Ulm, Germany
700    1_
$a Gremse, Felix $u Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany
700    1_
$a Theek, Benjamin $u Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany $u Fraunhofer MEVIS, Institute for Medical Image Computing, Aachen, Germany
700    1_
$a Kiessling, Fabian $u Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany $u Fraunhofer MEVIS, Institute for Medical Image Computing, Aachen, Germany
700    1_
$a Lammers, Twan $u Institute for Experimental Molecular Imaging (ExMI), University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany $u Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands $u Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands
773    0_
$w MED00177173 $t Theranostics $x 1838-7640 $g Roč. 10, č. 4 (2020), s. 1948-1959
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32042346 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507104852 $b ABA008
999    __
$a ok $b bmc $g 1651155 $s 1133301
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c 4 $d 1948-1959 $e 20200112 $i 1838-7640 $m Theranostics $n Theranostics $x MED00177173
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Archiving options